Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Pharmacodynamic Response of Fluticasone Propionate in Fixed-Dose Combination With Formoterol Fumarate in Subjects With COPD

NCT01168310 is registered in ClinicalTrials.gov with Dey as lead sponsor.

NCT NCT01168310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01168310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12-week Randomized, Multiple-Dose, Double-Blind, Placebo-Controlled, Parallel-Group Trial to Assess the Pharmacodynamic Response of Fluticasone Propionate in Fixed-Dose Combination With Formoterol Fumarate in Subjects With COPD
Lead sponsor
Dey
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2011
Enrollment
468 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease